VPIM
SANA icon

Vanguard Personalized Indexing Management’s Sana Biotechnology SANA Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$62.3K Buy
21,632
+1,453
+7% +$5.72K ﹤0.01% 2020
2025
Q4 		$82.1K Sell
20,179
-14
-0.1% -$63 ﹤0.01% 1834
2025
Q3 		$71.7K Buy
20,193
+508
+3% +$1.84K ﹤0.01% 1864
2025
Q2 		$53.7K Buy
19,685
+1,527
+8% +$3.15K ﹤0.01% 1817
2025
Q1 		$30.5K Sell
18,158
-36
-0.2% -$101 ﹤0.01% 1726
2024
Q4 		$29.7K Buy
+18,194
New +$54.3K ﹤0.01% 1740

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Vanguard Personalized Indexing Management's SANA Position: Q1 2026 in Review

Vanguard Personalized Indexing Management increased its Sana Biotechnology (SANA) stake by 7.2% in Q1 2026, buying an estimated $5.72K and bringing the position to 21,632 shares worth $62.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2020.

Vanguard Personalized Indexing Management first reported a position in SANA in Q4 2024 and has held it in 6 quarters since. The position peaked at $82.1K in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Vanguard Personalized Indexing Management held 21,632 shares of Sana Biotechnology worth $62.3K as of Q1 2026.
  • Vanguard Personalized Indexing Management bought 1,453 Sana Biotechnology shares in Q1 2026, an estimated $5.72K.
  • Sana Biotechnology made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #2020 holding.
  • Vanguard Personalized Indexing Management first reported a position in Sana Biotechnology in Q4 2024 and has held it in 6 quarters since.
  • Vanguard Personalized Indexing Management's Sana Biotechnology position peaked at $82.1K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.